You have accessJournal of UrologyCME1 Apr 2023PD38-10 DISPARITIES IN PSA TESTING RATES FOR VETERANS WITH SPINAL CORD INJURY Sarah Kodama, Mina P. Ghatas, Sarah C. Krzastek, Andrew T. Tracey, Lance L. Goetz, William Carter, Ronald T. Seel, B. Mayer Grob, Timothy Lavis, and Adam P. Klausner Sarah KodamaSarah Kodama More articles by this author , Mina P. GhatasMina P. Ghatas More articles by this author , Sarah C. KrzastekSarah C. Krzastek More articles by this author , Andrew T. TraceyAndrew T. Tracey More articles by this author , Lance L. GoetzLance L. Goetz More articles by this author , William CarterWilliam Carter More articles by this author , Ronald T. SeelRonald T. Seel More articles by this author , B. Mayer GrobB. Mayer Grob More articles by this author , Timothy LavisTimothy Lavis More articles by this author , and Adam P. KlausnerAdam P. Klausner More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003336.10AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Given a lack of published data regarding PSA testing rates in the spinal cord injury (SCI) population, there is concern for potential disparities and over-testing in this unique patient population. The purpose of this investigation was to identify and evaluate national PSA testing rates in Veterans with SCI. METHODS: Utilizing the Department of Veterans Affairs Informatics and Computing Infrastructure’s (VINCI) Corporate Data Warehouse, retrospective data extraction of was performed for PSA testing for all individuals with a diagnosis of SCI in the VA system using ICD-9 and ICD-10 codes. PSA testing rates were calculated, analyzed by race and age, and stratified according to published AUA guideline groupings for PSA testing. RESULTS: A total of 45,274 Veterans from 129 VA Medical Centers were identified with a diagnosis of SCI who had records of PSA testing between years 2000 and 2017. Male veterans who were only tested prior to SCI diagnosis were excluded from the analysis. Final cohort data analysis included 37,243 male Veterans who cumulatively underwent 261,125 post-SCI PSA tests during the given timeframe. For the entire population, average PSA testing rates for the age groups were 0.46 tests/year (≤39), 0.78 tests/year (40-54), 1.0 tests/year (55-69), and 0.91 tests/year (≥70). However, PSA testing rates were significantly higher for the AA group vs. the non-AA group at all ages (Figure 1, p<0.0005). CONCLUSIONS: Significant differences exist in rates of PSA testing in persons with SCI based on age and race. Higher than recommended testing rates were identified in all age groups, especially for AA Veterans (≥70 years). Source of Funding: This research was supported in part through funding from the Center for Rehabilitation Science and Engineering, VCU Health System © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e997 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Sarah Kodama More articles by this author Mina P. Ghatas More articles by this author Sarah C. Krzastek More articles by this author Andrew T. Tracey More articles by this author Lance L. Goetz More articles by this author William Carter More articles by this author Ronald T. Seel More articles by this author B. Mayer Grob More articles by this author Timothy Lavis More articles by this author Adam P. Klausner More articles by this author Expand All Advertisement PDF downloadLoading ...